Nanoparticulate Adjuvants and Delivery Systems for Allergen Immunotherapy
Figure 2
Immunomodulation of allergic diseases by using nanoparticle-based vaccines. Immunological changes after successful allergen specific-immunotherapy are indicated by whole arrows; truncated arrows indicate inhibitory effects. Redirection of allergic-TH2 responses, in favour of T regulatory cell induction or/and TH1 activation, are depicted.
